Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Discover Which Cryptocurrency Is Best To Start 2024 using a straightforward framework to compare potential coins and make a confident choice.
23,369 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
A senior MercadoLibre executive recently disclosed an open-market purchase, prompting questions about what this means...
XRP remains unable to break above $1.30, trading around the mid-$1.1s as traders weigh whether a reclaim $1.30? is wi...
Vice President Vance meets top Iranian officials at a Swiss resort to launch a fresh round of negotiations aimed at c...
Rocket Lab has been on a volatile ride as the space economy evolves. This guide explains why rocket stock keeps dropp...
Nasdaq’s CFO argues that AI is a leadership issue, not a back-office project. With 650 institutions using its AI-powe...
The S&P 500 closed near a decisive support level, raising the specter of additional losses if buyers fail to defend. ...
A year after taking the helm at Stellantis, Antonio Filosa faces a mixed bag: a Q1 2026 earnings beat, a historic 202...
A Florida grocery worker allegedly exploited lottery access to scan scratch-offs, netting tens of thousands in winnin...
As markets shift and longevity rises, a financial advisor says you’re likely undervaluing the need for flexible incom...
Google bought YouTube for $1.65 billion in 2006. The founders walked away with hundreds of millions, and today YouTub...